Terms: = Breast cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
79 results:
1. The emerging role of noncoding RNAs in the PI3K/AKT/mtor signalling pathway in breast cancer.
Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS
Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621
[TBL] [Abstract] [Full Text] [Related]
2. UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer.
Sun Q; Li J; Dong H; Zhan J; Xiong X; Ding J; Li Y; He L; Wang J
Sci Rep; 2023 May; 13(1):8335. PubMed ID: 37221238
[TBL] [Abstract] [Full Text] [Related]
3. Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mtor signaling pathway.
Song Q; Zhang W; Shi D; Zhang Z; Zhao Q; Wang M; Huang M; Meng J; Cui W; Luo X
Cancer Med; 2023 Jun; 12(12):13538-13550. PubMed ID: 37220224
[TBL] [Abstract] [Full Text] [Related]
4. The molecular landscape of breast mucoepidermoid carcinoma.
Venetis K; Sajjadi E; Ivanova M; Andaloro S; Pessina S; Zanetti C; Ranghiero A; Citelli G; Rossi C; Lucioni M; Malapelle U; Pagni F; Barberis M; Guerini-Rocco E; Viale G; Fusco N
Cancer Med; 2023 May; 12(9):10725-10737. PubMed ID: 36916425
[TBL] [Abstract] [Full Text] [Related]
5. Association Between Recreational Physical Activity and mtor Signaling Pathway Protein Expression in breast Tumor Tissue.
Cheng TD; Zhang R; Gong Z; Qin B; Cannioto RA; Datta S; Zhang W; Omilian AR; Yao S; Khoury T; Hong CC; Bandera EV; Ambrosone CB
Cancer Res Commun; 2023 Mar; 3(3):395-403. PubMed ID: 36895729
[TBL] [Abstract] [Full Text] [Related]
6. Aerobic exercise training resets the human skeletal muscle methylome 10 years after breast cancer treatment and survival.
Gorski PP; Raastad T; Ullrich M; Turner DC; Hallén J; Savari SI; Nilsen TS; Sharples AP
FASEB J; 2023 Jan; 37(1):e22720. PubMed ID: 36542473
[TBL] [Abstract] [Full Text] [Related]
7. Newly identified lncRNA-45 promotes breast cancer metastasis through activating the mtor signaling pathway.
Qiu J; Guo Y; Wang S; Ren Q; Dong Z; Gao M; Ma J; Chen S; Liu S
Biochem Biophys Res Commun; 2023 Jan; 640():40-49. PubMed ID: 36502630
[TBL] [Abstract] [Full Text] [Related]
8. The roles and mechanisms of circular RNAs related to mtor in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
9. Molecular perspective on targeted therapy in breast cancer: a review of current status.
Demir Cetinkaya B; Biray Avci C
Med Oncol; 2022 Jul; 39(10):149. PubMed ID: 35834030
[TBL] [Abstract] [Full Text] [Related]
10. LINC00092 Modulates Oxidative Stress and Glycolysis of breast cancer Cells via Pyruvate Carboxylase-Mediated AKT/mtor Pathway.
Chen W; Liu Y; Kang S; Lv X; Fu W; Zhang J; Song C
Oxid Med Cell Longev; 2022; 2022():5215748. PubMed ID: 35799892
[TBL] [Abstract] [Full Text] [Related]
11. breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression.
Cyrta J; Benoist C; Masliah-Planchon J; Vieira AF; Pierron G; Fuhrmann L; Richardot C; Caly M; Leclere R; Mariani O; Da Maia E; Larousserie F; Féron JG; Carton M; Renault V; Bidard FC; Vincent-Salomon A
Mod Pathol; 2022 Nov; 35(11):1624-1635. PubMed ID: 35697931
[TBL] [Abstract] [Full Text] [Related]
12. Global DNA Methylation Profiles in Peripheral Blood of WTC-Exposed Community Members with breast cancer.
Tuminello S; Zhang Y; Yang L; Durmus N; Snuderl M; Heguy A; Zeleniuch-Jacquotte A; Chen Y; Shao Y; Reibman J; Arslan AA
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564499
[TBL] [Abstract] [Full Text] [Related]
13. Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive breast cancer.
Xia S; Lin Q
Technol Cancer Res Treat; 2022; 21():15330338221090351. PubMed ID: 35450488
[TBL] [Abstract] [Full Text] [Related]
14. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mtor axis.
Wang L; Yang X; Zhou F; Sun X; Li S
Bioengineered; 2022 Mar; 13(3):7197-7208. PubMed ID: 35263216
[TBL] [Abstract] [Full Text] [Related]
15. ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase/mammalian target of rapamycin signaling pathway.
Lv C; Yang H; Yu J; Dai X
Environ Toxicol; 2022 Jun; 37(6):1423-1431. PubMed ID: 35191604
[TBL] [Abstract] [Full Text] [Related]
16. Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
Johansson A; Yu NY; Iftimi A; Tobin NP; van 't Veer L; Nordenskjöld B; Benz CC; Fornander T; Perez-Tenorio G; Stål O; Esserman LJ; Yau C; Lindström LS
Int J Cancer; 2022 Jun; 150(12):2072-2082. PubMed ID: 35179782
[TBL] [Abstract] [Full Text] [Related]
17. Single-nucleotide variant of PIK3CA
Cao G; Chen X; Deng Y; Nie F; Liu Y; Wang G; Huo D; Hou C
Anal Chim Acta; 2021 Oct; 1182():338943. PubMed ID: 34602188
[TBL] [Abstract] [Full Text] [Related]
18. Rag GTPases suppress PRL-3 degradation and predict poor clinical diagnosis of cancer patients with low PRL-3 mRNA expression.
Shi Y; Xu S; Ngoi NYL; Hui Y; Ye Z
Biochem Biophys Res Commun; 2021 Oct; 576():108-116. PubMed ID: 34482023
[TBL] [Abstract] [Full Text] [Related]
19. Cardioprotective Strategy for Patients With Nonmetastatic breast cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial.
Livi L; Barletta G; Martella F; Saieva C; Desideri I; Bacci C; Del Bene MR; Airoldi M; Amoroso D; Coltelli L; Scotti V; Becherini C; Visani L; Salvestrini V; Mariotti M; Pedani F; Bernini M; Sanchez L; Orzalesi L; Nori J; Bianchi S; Olivotto I; Meattini I
JAMA Oncol; 2021 Oct; 7(10):1544-1549. PubMed ID: 34436523
[TBL] [Abstract] [Full Text] [Related]
20. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Herranz C; Mateo F; Baiges A; Ruiz de Garibay G; Junza A; Johnson SR; Miller S; García N; Capellades J; Gómez A; Vidal A; Palomero L; Espín R; Extremera AI; Blommaert E; Revilla-López E; Saez B; Gómez-Ollés S; Ancochea J; Valenzuela C; Alonso T; Ussetti P; Laporta R; Xaubet A; Rodríguez-Portal JA; Montes-Worboys A; Machahua C; Bordas J; Menendez JA; Cruzado JM; Guiteras R; Bontoux C; La Motta C; Noguera-Castells A; Mancino M; Lastra E; Rigo-Bonnin R; Perales JC; Viñals F; Lahiguera A; Zhang X; Cuadras D; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Filippakis H; Hakem R; Gorrini C; Ferrer M; Ugun-Klusek A; Billett E; Radzikowska E; Casanova Á; Molina-Molina M; Roman A; Yanes O; Pujana MA
EMBO Mol Med; 2021 Sep; 13(9):e13929. PubMed ID: 34378323
[TBL] [Abstract] [Full Text] [Related]
[Next]
